Fully Human Antibodies, Acceleration of Discovery & Development

Mission

Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release

Breaking News

Individual Project Design, Fee for Service or Milestone-based

Contract Research, R&D Services

Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release

Breaking News

Partnered R&D, Collaborations, Licensing

Pipeline & Partnering

Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release

Breaking News

Breaking News

Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company Ymmunobio AG will optimize its cancer-directed antibody development programme using YUMABs antibody discovery platform .

Read press release

YUMAB® – Company

YUMAB is a world leading provider of contract research, technologies, and R&D services for the development of fully human, therapeutic antibodies. The YUMAB® platform is based on almost 30 years of continuous research by its founders in antibody discovery and engineering. It combines state of the art and next generation technologies from target to lead under one roof. YUMAB offers individually designed projects and business solutions for small biotech start-ups up to large biopharma companies.

News & Events

Ymmunobio signs collaboration agreement with YUMAB
June 14, 2022

Swiss biotech company Ymmunobio will collaborate with YUMAB to accelerate its drug development programme through antibody optimization.

CRO / R&D Services

YUMAB offers contract research, technologies and R&D services for the discovery and development of fully human, therapeutic antibodies.

YUMAB® Platform, Partnering

YUMAB also provides partnering and collaboration strategies to provide access to our technologies and expertise for academic spin-offs and start-up companies without the burden of technology access fees.

Contact

SEND US AN E-MAIL

YUMAB GMBH

Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany

Phone: (+49) 531-481170-0
Email: info@yumab.com

YUMAB Inc.

1100 South Tower
225 Peachtree Street NE
Atlanta, GA 30303 – USA

Phone: (+49) 531 481170-0
Email: info@yumab.com

Breaking News

Breaking News

Breaking News

Breaking News

YUMAB® – Company

News & Events

CRO / R&D Services

YUMAB® Platform, Partnering

Bioinformatic Optimizations

The Power of in vitro Selection

Fully Human Therapeutic Antibodies

Antibody Engineering

Nature-derived Antibody Libraries

YUMAB® – Versatile Platform Concept

Contact

SEND US AN E-MAIL

YUMAB GMBH

YUMAB Inc.

YUMAB GmbH

Newsletter

More Information